PREVENTION OF BLEEDING AFTER CARDIOPULMONARY BYPASS WITH HIGH-DOSE TRANEXAMIC ACID - DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL

被引:83
作者
KARSKI, JM [1 ]
TEASDALE, SJ [1 ]
NORMAN, P [1 ]
CARROLL, J [1 ]
VANKESSEL, K [1 ]
WONG, P [1 ]
GLYNN, MFX [1 ]
机构
[1] UNIV TORONTO, TORONTO HOSP, DEPT HEMATOL, DIV GEN, TORONTO, ON M5G 2C4, CANADA
关键词
D O I
10.1016/S0022-5223(95)70118-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This prospective, double-blind, randomized trial assessed the effectiveness of high-dose tranexamic acid given in the preoperative period on blood loss in patients undergoing cardiopulmonary bypass, One hundred fifty patients scheduled to undergo cardiac operations with cardiopulmonary bypass were randomized into three groups of equal size. The first group received 10 gm of tranexamic acid intravenously over 20 minutes before sternotomy and a placebo infusion over 5 hours, The second group received 10 gm of tranexamic acid over 20 minutes and then another 10 gm infused intravenously over 5 hours, The control group received a placebo bolus and a placebo infusion over 5 hours (0.9% normal saline solution), The blood loss after the operation was measured at 6 hours and 24 hours, The homologous blood and blood products given during and up to 38 hours after operation were recorded, Eighteen percent of the control group patients shed more than 750 ml blood in 6 hours compared with only 2% in both tranexamic acid groups. Patients who shed more than 750 mi blood required 93% more red blood cell transfusions than patients without excessive bleeding, Tranexamic acid (10 gm) given intravenously in the period before cardiopulmonary bypass reduced blood loss over 6 hours by 50% and over 24 hours by 35%. Continued tranexamic acid infusion (10 gm over 5 hours) did not reduce bleeding further. There was no difference in the coagulation profile before operation between patients with and without excessive bleeding, However, coagulation tests done in the postoperative period indicated ongoing fibrinolysis and platelet dysfunction in patients with excessive bleeding.
引用
收藏
页码:835 / 842
页数:8
相关论文
共 26 条
  • [1] COAGULATION, FIBRINOLYSIS AND BLEEDING AFTER OPEN-HEART-SURGERY
    BAGGE, L
    LILIENBERG, G
    NYSTROM, SO
    TYDEN, H
    [J]. SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 20 (02): : 151 - 160
  • [2] HEMOSTASIS DEFECTS ASSOCIATED WITH CARDIAC-SURGERY, PROSTHETIC DEVICES, AND OTHER EXTRACORPOREAL CIRCUITS
    BICK, RL
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (03) : 249 - 280
  • [3] CRAMER EM, 1991, BLOOD, V77, P694
  • [4] PROPHYLACTIC TREATMENT OF POSTPERFUSION BLEEDING USING EACA
    DELROSSI, AJ
    CERNAIANU, AC
    BOTROS, S
    LEMOLE, GM
    MOORE, R
    [J]. CHEST, 1989, 96 (01) : 27 - 30
  • [5] PHARMACOKINETICS OF TRANEXAMIC ACID AFTER INTRAVENOUS ADMINISTRATION TO NORMAL VOLUNTEERS
    ERIKSSON, O
    KJELLMAN, H
    PILBRANT, A
    SCHANNONG, M
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (05) : 375 - 380
  • [6] HOLLOWAY DS, 1988, THROMB HAEMOSTASIS, V59, P62
  • [7] HORROW JC, 1990, J THORAC CARDIOV SUR, V99, P70
  • [8] HEMOSTATIC EFFECTS OF TRANEXAMIC ACID AND DESMOPRESSIN DURING CARDIAC-SURGERY
    HORROW, JC
    VANRIPER, DF
    STRONG, MD
    BRODSKY, I
    PARMET, JL
    [J]. CIRCULATION, 1991, 84 (05) : 2063 - 2070
  • [9] HOYLAERTS M, 1981, BIOCHIM BIOPHYS ACTA, V673, P75
  • [10] MECHANISM OF THE PRESERVING EFFECT OF APROTININ ON PLATELET-FUNCTION AND ITS USE IN CARDIAC-SURGERY
    HUANG, HM
    DING, WX
    SU, ZK
    ZHANG, WZ
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (01) : 11 - 18